MIRA Pharmaceuticals (MIRA)

• Market cap: $61.6M
• 1 day: 1.38%
• 5 days: 5%
• 1 month: -11.98%
• 3 months: 5.76%
• 6 months: 16.67%
• Year to date: 27.83%
• 1 year: 14.84%
• 5 years: -80.19%
• 10 years: -80.19%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Employees: 5